Nerve Stimulator Co. Again Beats Investor Suit Over $78M IPO
An investor in bioelectronic medicine company electroCore Inc. will have one final shot at revising her proposed class action alleging that the company misrepresented the types and scope of agreements the...To view the full article, register now.
Already a subscriber? Click here to view full article